Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Aug-24 8:49 PM View:  | Actuate Therapeutics, Inc. (ACTU) | 14-Aug-24 | Conversion Duplicate | 9,380,700 | -- | -- | 464% 2.02M to 11.4M | |
| 14-Aug-24 8:49 PM View: | Actuate Therapeutics, Inc. (ACTU) | 14-Aug-24 | Private Purchase Duplicate | 500,000 | $8.00 | $4,000,000.00 | 4% 11.4M to 11.9M | |
| 14-Aug-24 8:49 PM View: | Actuate Therapeutics, Inc. (ACTU) | 14-Aug-24 | Market Sale Duplicate | 24,999 | $9.00 | $224,991.00 | (< 1%) 11.94M to 11.92M | |
| 14-Aug-24 8:49 PM View: | Actuate Therapeutics, Inc. (ACTU) | 14-Aug-24 | Exercise (in-the money or at-the-money) Duplicate | 37,951 | $5.27 | $200,002.00 | < 1% 11.9M to 11.94M | |
| 11-Jun-24 9:32 PM View: | Cognition Therapeutics Inc (CGTX) | 07-Jun-24 | Grant | 8,500 | -- | -- | < 1% 6.01M to 6.01M | |
| 28-May-24 4:30 PM View: | Lantern Pharma Inc. (LTRN) | 24-May-24 | Market Sale | 20,000 | $6.33 | $126,600.00 | (2%) 1.25M to 1.23M | (17%) |
| 28-May-24 4:30 PM View: | Lantern Pharma Inc. (LTRN) | 23-May-24 | Market Sale | 10,000 | $6.25 | $62,500.00 | (< 1%) 1.26M to 1.25M | (19%) |
| 29-Feb-24 9:54 PM View: | Lantern Pharma Inc. (LTRN) | 29-Feb-24 | Sale Duplicate | 19,703 | $4.87 | $95,953.60 | (2%) 1.28M to 1.26M | |
| 29-Feb-24 9:54 PM View: | Lantern Pharma Inc. (LTRN) | 28-Feb-24 | Sale Duplicate | 74,297 | $4.85 | $360,340.00 | (5%) 1.36M to 1.28M | |
| 29-Feb-24 9:54 PM View: | Lantern Pharma Inc. (LTRN) | 27-Feb-24 | Sale Duplicate | 50,000 | $4.40 | $220,000.00 | (4%) 1.41M to 1.36M | |
| 19-Jan-24 4:31 PM View: | Lantern Pharma Inc. (LTRN) | 17-Jan-24 | Sale Duplicate | 58,889 | $4.20 | $247,334.00 | (4%) 1.47M to 1.41M | |
| 19-Jan-24 4:31 PM View: | Lantern Pharma Inc. (LTRN) | 17-Jan-24 | Exercise (in-the money or at-the-money) Duplicate | 79,021 | $3.13 | $247,336.00 | 6% 1.39M to 1.47M | |
| 01-Dec-23 6:01 AM View: | Lantern Pharma Inc. (LTRN) | 29-Nov-23 | Sale | 145,348 | $3.44 | $499,997.00 | (9%) 1.53M to 1.39M | |
| 13-Nov-23 9:47 AM View: | Cognition Therapeutics Inc (CGTX) | 08-Nov-23 | Grant Duplicate | 500,095 | $1.05 | $525,100.00 | 9% 5.51M to 6.01M | |
| 23-Jun-23 9:37 PM View: | Azitra, Inc. (AZTR) | 21-Jun-23 | Conversion | 4,354,870 | -- | -- | 524% 831.34K to 5.19M | |
| 23-Jun-23 9:37 PM View: | Azitra, Inc. (AZTR) | 21-Jun-23 | Purchase | 2,297,490 | $1.31 | $3,000,000.00 | 44% 5.19M to 7.48M | |
| 23-Jun-23 9:37 PM View: | Azitra, Inc. (AZTR) | 21-Jun-23 | Sale | 669,317 | -- | -- | (9%) 7.48M to 6.81M | |
| 13-Jun-23 10:00 PM View: | Cognition Therapeutics Inc (CGTX) | 09-Jun-23 | Grant | 6,000 | -- | -- | < 1% 5.5M to 5.51M | |
| 13-Dec-22 7:00 AM View: | In8bio, Inc. (INAB) | 12-Dec-22 | Private Purchase | 75,001 | $2.48 | $185,912.00 | < 1% 8.52M to 8.6M | |
| 29-Nov-22 7:02 AM View: | Cognition Therapeutics Inc (CGTX) | 28-Nov-22 | Private Purchase Duplicate | 16,064 | $2.65 | $42,564.80 | < 1% 5.48M to 5.5M | |
| 23-Nov-22 7:59 AM View: | Tff Pharmaceuticals, Inc. (TFFP) | 22-Nov-22 | Private Purchase | 43,470 | $1.15 | $49,990.50 | 6% 751.6K to 795.07K | |
| 17-Nov-22 7:00 AM View: | Cognition Therapeutics Inc (CGTX) | 16-Nov-22 | Private Purchase Duplicate | 71,000 | $1.40 | $99,400.00 | 1% 5.41M to 5.48M | |
| 16-Nov-22 7:00 AM View: | Cognition Therapeutics Inc (CGTX) | 15-Nov-22 | Private Purchase Duplicate | 1,500,000 | $1.20 | $1,800,000.00 | 38% 3.91M to 5.41M | |
| 09-Nov-22 9:37 PM View: | Lantern Pharma Inc. (LTRN) | 08-Nov-22 | Sale | 350,000 | $4.40 | $1,540,000.00 | (19%) 1.88M to 1.53M | |
| 29-Sep-22 6:14 AM View: | In8bio, Inc. (INAB) | 28-Sep-22 | Private Purchase Duplicate | 25,000 | $2.02 | $50,535.00 | < 1% 8.5M to 8.53M | |
| 07-Sep-22 4:55 PM View: | Lantern Pharma Inc. (LTRN) | 02-Sep-22 | Sale Duplicate | 6,445 | $5.20 | $33,514.00 | (< 1%) 1.89M to 1.88M | |
| 07-Sep-22 4:55 PM View: | Lantern Pharma Inc. (LTRN) | 02-Sep-22 | Exercise (in-the money or at-the-money) Duplicate | 32,538 | $1.03 | $33,514.10 | 2% 1.86M to 1.89M | |
| 30-Aug-22 1:16 PM View: | In8bio, Inc. (INAB) | 29-Aug-22 | Purchase Duplicate | 40,000 | $2.02 | $80,800.00 | < 1% 8.46M to 8.5M | |
| 30-Aug-22 1:16 PM View: | In8bio, Inc. (INAB) | 26-Aug-22 | Private Purchase Duplicate | 11,214 | $2.01 | $22,540.10 | < 1% 8.45M to 8.46M | |
| 18-Aug-22 7:16 PM View: | In8bio, Inc. (INAB) | 17-Aug-22 | Private Purchase | 50,000 | $1.93 | $96,500.00 | < 1% 8.4M to 8.45M | |
| 17-Aug-22 10:25 AM View: | In8bio, Inc. (INAB) | 16-Aug-22 | Private Purchase | 1,773,680 | $1.90 | $3,370,000.00 | 28% 6.37M to 8.14M | |
| 25-May-22 9:09 AM View: | Cue Biopharma, Inc. (CUE) | 24-May-22 | Purchase | 55,000 | $3.34 | $183,700.00 | 5% 1.06M to 1.11M | |
| 25-May-22 9:09 AM View: | Cue Biopharma, Inc. (CUE) | 23-May-22 | Private Purchase | 150,000 | $3.52 | $528,000.00 | 17% 908.87K to 1.06M | |
| 17-May-22 9:57 PM View: | Tff Pharmaceuticals, Inc. (TFFP) | 17-May-22 | Purchase | 24,600 | $5.08 | $124,968.00 | 3% 727.0K to 751.6K | |
| 17-May-22 9:57 PM View: | Tff Pharmaceuticals, Inc. (TFFP) | 16-May-22 | Private Purchase | 85,000 | $4.86 | $413,100.00 | 13% 642.0K to 727.0K | |
| 04-Apr-22 6:34 PM View: | Tff Pharmaceuticals, Inc. (TFFP) | 04-Apr-22 | Private Purchase | 542,000 | $6.47 | $3,504,380.00 | 90% 600.0K to 1.14M | |
| 04-Apr-22 5:28 PM View: | Cue Biopharma, Inc. (CUE) | 31-Mar-22 | Private Purchase | 735,000 | $4.76 | $3,498,600.00 | 423% 173.87K to 908.87K | |
| 03-Jan-22 7:38 PM View: | KANA Software Inc. (SWKH) | 31-Dec-21 | Grant | 250 | -- | -- | 2% 10.99K to 11.24K | |
| 12-Jan-22 2:20 PM View: | KANA Software Inc. (SWKH) | 31-Dec-21 | Disposition | 1,363 | -- | -- | (12%) 11.24K to 9.87K | |
| 15-Oct-21 9:51 PM View: | Cognition Therapeutics Inc (CGTX) | 13-Oct-21 | Conversion | 3,689,440 | -- | -- | (491925000%) 0 to 3.69M | |
| 15-Oct-21 9:51 PM View: | Cognition Therapeutics Inc (CGTX) | 13-Oct-21 | Market Purchase | 190,000 | $12.00 | $2,280,000.00 | 5% 3.69M to 3.88M | |
| 15-Oct-21 9:51 PM View: | Cognition Therapeutics Inc (CGTX) | 13-Oct-21 | Market Sale | 90 | $12.00 | $1,083.36 | (< 1%) 3.91M to 3.91M | |
| 15-Oct-21 9:51 PM View: | Cognition Therapeutics Inc (CGTX) | 13-Oct-21 | Exercise (in-the money or at-the-money) | 33,495 | $0.03 | $1,071.84 | < 1% 3.88M to 3.91M | |
| 01-Oct-21 5:49 PM View: | KANA Software Inc. (SWKH) | 01-Oct-21 | Grant | 1,363 | -- | -- | 14% 9.62K to 10.99K | |
| 01-Oct-21 5:49 PM View: | KANA Software Inc. (SWKH) | 30-Sep-21 | Grant | 250 | -- | -- | 3% 9.37K to 9.62K | |
| 03-Aug-21 10:00 PM View: | In8bio, Inc. (INAB) | 03-Aug-21 | Conversion | 6,625,100 | -- | -- | 100% 0 to 6.63M | |
| 30-Jun-21 5:54 PM View: | KANA Software Inc. (SWKH) | 30-Jun-21 | Grant | 250 | -- | -- | 3% 9.12K to 9.37K | |
| 01-Apr-21 3:38 PM View: | KANA Software Inc. (SWKH) | 31-Mar-21 | Grant | 250 | -- | -- | 3% 8.87K to 9.12K | |
| 04-Jan-21 3:42 PM View: | KANA Software Inc. (SWKH) | 31-Dec-20 | Grant | 250 | -- | -- | 3% 8.62K to 8.87K | |
| 25-Nov-20 4:09 PM View: | Cue Biopharma, Inc. (CUE) | 24-Nov-20 | Market Purchase | 6,548 | $12.64 | $82,775.90 | 4% 167.32K to 173.87K | 3% |